Osimertinib Versus First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Metastatic EGFR-Mutant Non–Small Cell Lung Cancer: A Target Trial Emulation Study of Real-World ...
Fifteen-Year National Trends in Single-Fraction Stereotactic Body Radiation Therapy Utilization for Stage I Non–Small Cell Lung Cancer Despite the increase in SF-SBRT over time, the overall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results